In our study, multiple MINAS patients developed cancer before the age of 50, and some exhibited tumor types associated with both mutated genes—such as the combination of BRCA1 and MUTYH, suggesting additive or synergistic effects (El Tekle et al., 2021). This evidence concerns the gene BRCA1 and neoplasm.